When 12 MCPs in eight IBD-patients were compared to six non-IBD patients at inclusion, significantly higher values of IL-12β (p = 0.007) and IL-23α (p = 0.025) were measured in the IBD patients compared to non-IBD controls. Here, IL23A is linked to inflammatory bowel disease.